(Q36623473)
Statements
1 reference
A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancer (English)
1 reference
James ND
1 reference
Atherton PJ
1 reference
Jones J
1 reference
Howie AJ
1 reference
Tchekmedyian S
1 reference
Curnow RT
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference